Azenta Inc at Barclays Global Healthcare Conference Transcript
Good morning, everybody. My name is Luke Sergott. I cover Life Science Tools and Diagnostics at Barclays. It's my pleasure here to have Lindon from Azenta Life Sciences. And with that, I'll just let you kick off. We're going to do a presentation. There's going to be a couple of Q&A.
Great. Luke, thank you very much. It's a real pleasure to be here at the Barclays Health Care Conference. And amazingly feels like normal this morning with so many people in the labor conference, so thanks for including us.
With a lot of excitement, we present the Azenta company. Of course, first of all, I'll highlight the safe harbor statement. We'll make some projection comments. And of course, as always, I'm not obligated to update those, but we do frequent communication so I don't think you'll find us hard to read here.
The agenda today, we're going to give you an overview of the business. We launched the company as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |